American Gene Technologies (AGT) practices the art and science of genetic medicine. AGTrobust programs of discovery and drug development also include efforts on research and development of genetic medicines for treating Parkinsondisease and familial dysautonomia a rare, inherited orphan disease that is characterized by early onset blindness and other neurological problems. As priority programs move toward clinical testing, and as AGT continues to grow, these and other areas of investigation will expand and refine the genetic medicine strategies while advancing toward the clinic alongside other focus areas.